BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

  July 14, 2026

   · 

  8 min read
• 

  Alzheimer’s disease

  Biogen, Eisai win FDA nod for starter dose of subcutaneous Leqembi

  Leqembi Iqlik can now be given at home throughout the entire course of treatment, setting it apart from Eli Lilly’s Kisunla, the only other anti-amyloid Alzheimer’s disease therapy on the market.

  July 14, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Lung cancer

  AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B

  Dizal Pharmaceutical’s Zegfrovy is approved in the U.S. for locally advanced or metastatic non-small cell lung cancer. For $600 million upfront, AstraZeneca will gain global rights to advance and commercialize the asset.

  July 14, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

  July 14, 2026

   · 

  3 min read
• Press Releases

  InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

  July 14, 2026

   · 

  3 min read
• Press Releases

  Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

  July 14, 2026

   · 

  6 min read
• Press Releases

  Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

  July 14, 2026

   · 

  4 min read
• Press Releases

  Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

  July 14, 2026

   · 

  7 min read
• Press Releases

  Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

  July 14, 2026

   · 

  5 min read
• Press Releases

  Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

  July 14, 2026

   · 

  4 min read